Balloon Catheter

Medtronic, IN.PACT Admiral DCB, drug-coated balloon, below-the-knee, European BTK IN.PACT clinical study, peripheral artery disease, PAD, launch
News | Peripheral Arterial Disease (PAD) | March 09, 2017

March 9, 2017 — Medtronic plc announced the launch of the IN.PACT BTK study to evaluate the effectiveness of a...

Medtronic, IDE approval, IN.PACT Admiral drug-coated balloon, DCB, end-stage renal disease
News | Drug-Eluting Balloons | February 08, 2017

February 8, 2017 — Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food...

Spectranetics, Stellarex 0.014-inch DCB, CE Mark
News | Drug-Eluting Balloons | December 06, 2016

December 6, 2016 — The Spectranetics Corp. announced in late November that its Stellarex 0.014-inch...

Videos | Balloon Catheter | November 16, 2016

A discussion with Todd Brinton, M.D., about the newly FDA-cleared Shockwave Medical Lithoplasty System, at the...

Bard, Lutonix 014 DCB, drug-coated balloon, six-month endpoint, FDA IDE trial
Technology | Drug-Eluting Balloons | September 26, 2016

September 26, 2016 — C. R. Bard Inc. announced the U.S. Food and Drug Administration (FDA) approved an...

Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons | September 22, 2016

September 22, 2016 — New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the...

Medtronic, IN.PACT Admiral drug-coated balloon, DCB, FDA approval, in-stent restenosis, ISR
Technology | Drug-Eluting Balloons | September 19, 2016

September 19, 2016 — Medtronic plc announced that the U.S. Food and Drug Administration (FDA) approved the IN.PACT...

lithoplasty, lithotripsy for arteries

The Shockwave Medical Lithoplasty system combines a balloon catheter with tiny lithotripsy electrodes that emit pulses to crack and break up calcium in peripheral arteries.

Technology | Peripheral Arterial Disease (PAD) | September 16, 2016

September 16, 2016 — The U.S. Food and Drug Administration (FDA) has granted market clearance for Shockwave Medical’...

Videos | Peripheral Arterial Disease (PAD) | September 16, 2016

Shockwave Medical’s Lithoplasty System uses ultrasonic waves to treatment calcified plaque in patients with...

VIVA 2016, late breaking trials, cath lab
Feature | Cath Lab | September 14, 2016

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular...

Medtronic, In.Pact Admiral drug coated balloon, DCB, FDA approval, 150 mm length
Technology | Drug-Eluting Balloons | July 18, 2016

July 18, 2016 — Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for the IN.PACT Admiral...

News | Drug-Eluting Balloons | June 03, 2016

June 3, 2016 — Cardionovum GmbH recently announced the completion of enrollment of the RAPID trial. Results will be...

TOBA-BTK study, twelve-month results, SCAI 2016, Tack Endovascular System, critical limb ischemia
News | Peripheral Arterial Disease (PAD) | May 05, 2016

May 5, 2016 — Intact Vascular Inc. announced that positive twelve-month results from its Tack Optimized Balloon...

NuCryo Vascular, Next Generation Cryoplasty Inflation Device, PolarCath Balloon Dilatation System

PolarCath Balloon Dilatation System image courtesy of NuCryo Vascular

Technology | Balloon Catheter | March 28, 2016

March 28, 2016 — NuCryo Vascular LLC announced the launch of the Next Generation Cryoplasty Inflation device. The...

PinnacleHealth Cardiovascular Institute, TOBA II study, first patient, Tack Endovascular System, PAD
News | Peripheral Arterial Disease (PAD) | March 22, 2016

March 22, 2016 — PinnacleHealth CardioVascular Institute enrolled the first patient in Pennsylvania into the TOBA II...

Overlay Init